Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: J Pediatr. 2022 Dec 16;256:98–104.e6. doi: 10.1016/j.jpeds.2022.12.007

Table 4.

Influence of CRP measurements on management of infants without EOS

CRP high1 N = 1,934 CRP low2 N = 5,476 P value
Characteristics
 Sex (male) 1,184 (61.2) 2,981 (54.4) <0.001
 Cesarean delivery 890 (46.0) 2,741 (50.1) 0.002
 Gestational age, wk 39 (36, 40) 36 (33, 39) <0.001
 Birth weight, g 3250 (2550, 3640) 2680 (1931, 3330) <0.001
 Length of stay by gestational age, d
  <37 wk 38 (13, 69) 17 (8, 37) <0.001
  ≥37 wk 4 (3, 7) 3 (2, 4) <0.001
Management and outcomes in day 0–3
 CSF culture obtained 636 (32.9) 424 (7.7) <0.001
 CSF culture positive for a pathogen 0 0 N/A
 Antibiotics initiated 1,884 (97.4) 4,777 (87.2) <0.001
  Antibiotics continued for >2 d 821 (43.6) 788 (16.5) <0.001
  Antibiotics other than penicillin, ampicillin and gentamicin given 125 (6.6) 159 (3.3) <0.001
   Vancomycin 83 (66.4) 130 (81.8) 0.003
   Cephalosporins 95 (76.0) 101 (63.5) 0.02
   Metronidazole 8 (6.4) 8 (5.0) 0.62
Management and outcomes in day 4–7
 Blood culture obtained 62 (3.2) 202 (3.7) 0.33
 CSF culture obtained 71 (3.7) 83 (1.5) <0.001
 Blood culture positive for a pathogen 4 (0.2) 24 (0.4) 0.20
 CSF culture positive for a pathogen 1 (0.1) 0 0.26

Data presented as n (%) or median (Q1, Q3). All infants in the table had a blood culture obtained in days 0–3 which was not positive for a pathogen.

1

Includes infants who had at least one CRP value ≥10 mg/L in days 0–3.

2

Includes infants with all CRP values <10 mg/L in days 0–3.

Abbreviations – CRP, C-reactive protein; CSF, cerebrospinal fluid; EOS, early-onset sepsis.